Literature DB >> 29162310

Therapeutic Mechanisms of Glucocorticoids.

Jolien Vandewalle1, Astrid Luypaert2, Karolien De Bosscher2, Claude Libert3.   

Abstract

Glucocorticoids (GCs) have been used clinically for decades as potent anti-inflammatory and immunosuppressive agents. Nevertheless, their use is severely hampered by the risk of developing side effects and the occurrence of glucocorticoid resistance (GCR). Therefore, efforts to understand the complex mechanisms underlying GC function and GCR are ongoing. The goal is to generate new glucocorticoid receptor (GR) ligands that can dissociate anti-inflammatory from metabolic side effects and/or overcome GCR. In this review paper we discuss recent insights into GR-mediated actions in GCR and novel therapeutic strategies for acute and chronic inflammatory diseases.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  glucocorticoid receptor; glucocorticoid resistance; inflammatory diseases; monomer–dimer concept; side effects

Mesh:

Substances:

Year:  2017        PMID: 29162310     DOI: 10.1016/j.tem.2017.10.010

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  121 in total

Review 1.  Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease.

Authors:  Tomomi Toubai; John Magenau
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 2.  Nuclear receptor crosstalk - defining the mechanisms for therapeutic innovation.

Authors:  Karolien De Bosscher; Sofie J Desmet; Dorien Clarisse; Eva Estébanez-Perpiña; Luc Brunsveld
Journal:  Nat Rev Endocrinol       Date:  2020-04-17       Impact factor: 43.330

Review 3.  Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.

Authors:  Pojchong Chotiyarnwong; Eugene V McCloskey
Journal:  Nat Rev Endocrinol       Date:  2020-04-14       Impact factor: 43.330

4.  Glucocorticoids limit lipopolysaccharide-induced lethal inflammation by a double control system.

Authors:  Kelly Van Looveren; Steven Timmermans; Tineke Vanderhaeghen; Charlotte Wallaeys; Marlies Ballegeer; Jolien Souffriau; Melanie Eggermont; Jolien Vandewalle; Lise Van Wyngene; Karolien De Bosscher; Claude Libert
Journal:  EMBO Rep       Date:  2020-05-08       Impact factor: 8.807

5.  Role of Mineralocorticoid Receptor in Adipogenesis and Obesity in Male Mice.

Authors:  Daniel Ferguson; Irina Hutson; Eric Tycksen; Terri A Pietka; Kevin Bauerle; Charles A Harris
Journal:  Endocrinology       Date:  2020-02-01       Impact factor: 4.736

6.  Transcriptomic Network Interactions in Human Skin Treated with Topical Glucocorticoid Clobetasol Propionate.

Authors:  Loukia N Lili; Anna Klopot; Benjamin Readhead; Gleb Baida; Joel T Dudley; Irina Budunova
Journal:  J Invest Dermatol       Date:  2019-06-25       Impact factor: 8.551

7.  Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment.

Authors:  Xu Liu; Yashuo Wang; Jennifer S Gutierrez; Jesse M Damsker; Kanneboyina Nagaraju; Eric P Hoffman; Eric A Ortlund
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-11       Impact factor: 11.205

8.  Obesity-induced excess of 17-hydroxyprogesterone promotes hyperglycemia through activation of glucocorticoid receptor.

Authors:  Yan Lu; E Wang; Ying Chen; Bing Zhou; Jiejie Zhao; Liping Xiang; Yiling Qian; Jingjing Jiang; Lin Zhao; Xuelian Xiong; Zhiqiang Lu; Duojiao Wu; Bin Liu; Jing Yan; Rong Zhang; Huijie Zhang; Cheng Hu; Xiaoying Li
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

9.  THE EFFECTS OF VARIOUS DOSES OF PREDNISOLONE ADMINISTRATION ON SERUM VASPIN LEVELS IN RATS.

Authors:  K Noyin; E Akpinar; E Cadirci; I Cinar; P Aydin
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jul-Sep       Impact factor: 0.877

Review 10.  Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.

Authors:  Sherif A Gaballa; Uday B Kompella; Omar Elgarhy; Ali M Alqahtani; Barbara Pierscionek; Raid G Alany; Hamdy Abdelkader
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.